Moxalactam

• Description :

  Moxalactam (Latamoxef) is a synthetic oxa-β-lactam antibiotic. Moxalactam has a broad spectrum of activity against Gram-positive and Gram-negative aerobic and anaerobic bacteria. Moxalactam inhibits production of β-lactamases[1].

• CAS Number :

  [64952-97-2]

• Product Name Alternative :

  Latamoxef; Lamoxactam; LY-127935

• UNSPSC :

  12352005

• Hazard Statement :

  H302-H312-H332

• Target :

  Antibiotic; Bacterial; Beta-lactamase

• Type :

  Reference compound

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/moxalactam.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(C(N12)=C(CSC3=NN=NN3C)CO[C@]2([H])[C@](OC)(NC(C(C(O)=O)C4=CC=C(O)C=C4)=O)C1=O)O

• Molecular Formula :

  C20H20N6O9S

• Molecular Weight :

  520.47

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P363-P501

• References & Citations :

  [1]Carmine AA, et al. Moxalactam (latamoxef) . A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1983 Oct;26 (4) :279-333.|[2]Goto S. In vitro and in vivo antibacterial activity of moxalactam, an oxa-β-lactam antibiotic. Clinical Infectious Diseases, 1982, 4 (Supplement_3) : S501-S510.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Launched

• Isoform :

  β-lactam